Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.



On June 21, 2022, Chirfi Guindo, Executive Vice President for Global Product
Strategy and Commercialization announced that he has accepted a new role outside
of Biogen, Inc. (the "Company"). His last day at the Company will be June 30,
2022.

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 15, 2022, the Company held its 2022 Annual Meeting of Stockholders (the "Annual Meeting"). The final voting results for the Annual Meeting are as follows:

1. Stockholders elected eleven nominees to the Board of Directors to serve

for a one-year term extending until the 2023 annual meeting of

stockholders and their successors are duly elected and qualified, with

the votes cast as follows:





Nominee                                Votes For        Votes Against      Abstentions       Broker Non-Votes
Alexander J. Denner                     82,710,582          32,524,166          664,096             10,427,787
Caroline D. Dorsa                       85,668,149          30,030,982          199,713             10,427,787
Maria C. Freire                         97,086,534          18,535,399          276,911             10,427,787
William A. Hawkins                      97,324,728          18,022,577          551,539             10,427,787
William D. Jones                        94,369,405          21,054,650          474,789             10,427,787
Jesus B. Mantas                         95,166,348          20,524,662          207,834             10,427,787
Richard C. Mulligan                     77,425,358          38,265,020          208,466             10,427,787
Stelios Papadopoulos                    84,568,511          30,032,987        1,297,346             10,427,787
Eric K. Rowinsky                        70,055,541          45,638,693          204,610             10,427,787
Stephen A. Sherwin                      93,163,597          22,472,670          262,577             10,427,787
Michel Vounatsos                        96,731,803          18,993,619          173,422             10,427,787



    2.   Stockholders ratified the selection of PricewaterhouseCoopers LLP as the
         Company's independent registered public accounting firm for the fiscal
         year ending December 31, 2022, with the votes cast as follows:



 Votes For    Votes Against   Abstentions   Broker Non-Votes
123,821,993     2,300,275       204,363            -



    3.   Stockholders approved the advisory vote on executive compensation, with
         the votes cast as follows:



Votes For    Votes Against   Abstentions   Broker Non-Votes
60,099,277    55,305,837       493,730        10,427,787

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits


The exhibits listed below are furnished as part of this Current Report on Form
8-K.

Exhibit No.                                  Description

104               Cover Page Interactive Data File (embedded within the Inline XBRL
                  document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses